• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Thyme Care Appoints Dr. Brad Diephuis as CEO, Co-Founder Robin Shah Appointed Executive Chairman

by Healthcare Executive Hires 07/15/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Thyme Care Appoints Dr. Brad Diephuis as CEO, Co-Founder Robin Shah Appointed Executive Chairman
Dr. Brad Diephuis, CEO at Thyme Care

What You Should Know

  • Value-based oncology leader Thyme Care has announced a comprehensive executive succession matrix: co-founder Robin Shah will transition to executive chairman, while current president and COO Brad Diephuis, M.D., will step into the CEO role, effective September 1, 2026.
  • Dr. Diephuis, a primary care physician and cancer survivor, brings deep value-based policy expertise to the chief executive seat, having previously served as a senior advisor at the Center for Medicare and Medicaid Innovation (CMMI) where he helped design total cost of care frameworks like ACO REACH.
  • To fill the operational vacancy, the company has recruited Marcia Macphearson as Chief Operating Officer, bringing 25 years of healthcare expertise from her previous roles as Chief Commercial Officer at Imagine Pediatrics and senior partner at Oliver Wyman.

Engineering Downstream Inpatient Diversion

The underlying architecture driving Thyme Care’s market expansion moves completely away from generic care navigation apps to enforce a rigid, clinically embedded model of whole-patient oversight. Founded in 2020 by Shah and prominent medical oncologist Bobby Green, M.D. (who continues as president and chief medical officer), the company operates by establishing full financial accountability across all 50 states.

Rather than functioning as an external, distracting vendor layer that causes provider friction, Thyme Care integrates its dedicated clinical teams and purpose-built software platform straight into existing practice workflows.

This complete integration allows Thyme Care to intercept acute complications in the critical moments between standard office appointments. The operational validation of this model is supported by strict, real-world data released in the company’s annual Impact Report today:

  • Inpatient Reduction Moat: The platform achieves a verified 16% reduction in all-cause inpatient utilization for one national Medicare Advantage client’s eligible member cohort.
  • Avoidable Readmission Prevention: For members completing Thyme Care’s specialized readmission prevention program, the technology drives a 30% drop in avoidable readmissions.
  • Total Cost of Care Compression: By aligning treatment choice with clinical necessity, the infrastructure captures an immediate 10% decrease in total cost of care for partnering health plans.

“For too long, the responsibility for what happens in cancer care has been spread across so many parties that no one is connecting the dots for the person living through it,” stated Dr. Brad Diephuis, incoming CEO. “As CEO, I am committed to making sure that every patient, clinician, and health plan we work with experiences a system that finally moves together.”


CMMI Heritage: Weaponizing Policy for Commercial Scalability

The primary commercial advantage driving Thyme Care’s next phase of enterprise scaling sits within the unique policy background of its incoming chief executive. Dr. Diephuis is a primary care physician who previously served as a senior advisor at the Center for Medicare and Medicaid Innovation (CMMI), where he was central to shaping the nation’s total cost of care models, including the design of ACO REACH. This deep structural understanding of public sector risk management equips Thyme Care with an exceptional asset at a time when CMS is aggressively moving the entire market toward technology-enabled, outcomes-based chronic disease networks.

By pairing this CMMI policy design expertise with the operational execution of Marcia Macphearson—who spent a decade directing enterprise health plan strategy at consulting giant Oliver Wyman—Thyme Care is uniquely positioned to handle intense operational complexity.

As Robin Shah assumes the executive chairman seat to launch targeted solutions addressing drug price volatility and clinical trial access deficits, the platform leverages its massive 10.5 million covered life footprint to eliminate traditional administrative blind spots, providing employers and plan sponsors with complete real-time visibility into their actual longitudinal healthcare spend.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Digital Health Hires

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |